搜尋結果
Red-Hot Prescription Stock Flashing A Bullish Signal
Forbes· 2 日前Prescription stock Hims & Hers Health (HIMS) is down 2.8% to trade at $22.45 today, and last week suffered ...
Author Post: The Longevity Movement: What to Make of the Hype
Forbes· 2 日前High-end gym chain Equinox introduced a longevity program with a $40,000 annual membership that ...
Council Post: How Tech Leaders Can Better Communicate With Peers And Stakeholders
Forbes· 2 日前It can be especially difficult for new tech leaders, who must explain the function, benefits an ...
How NIL Changed The Game For Gymnasts Gearing Up For Paris Olympics
Forbes· 2 日前Read on to see why NIL is so important to collegiate athletes, how athletes like reigning ...
From Presidential Races To Popcorn Flicks: How Polymarket Predicts The Future
Forbes· 2 日前John Scott Haldane, a pioneering engineer and the "father of oxygen therapy," ...
Council Post: Four Important Practices Amid GLP-1 Medications Reshaping Healthcare
Forbes· 2 日前Nicole Faucher provides leadership for Clearway Health’s executive team, oversees strategic, ...
Council Post: Multimodal Forecasting In Healthcare: Opportunities And Challenges
Forbes· 2 日前A post by Eric Topol on the importance of medical forecasting caught my attention. In his ...
If You Like Your Health Care Plan, Will Kamala Harris Let You Keep It?
Forbes· 2 日前In 2008, then-Senator Barack Obama launched the largest political advertising campaign of all ...
Growth Portfolio Will Likely Drive Bristol Myers Squibb's Q2
Forbes· 2 日前Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2024 results on Friday, July 26. ...
Council Post: Strengthen Your Business By Putting Your Values Into Action
Forbes· 2 日前Kendra Davenport is the President and CEO of Easterseals. Want happier, more engaged employees? ...